BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1385 related articles for article (PubMed ID: 26058718)

  • 1. Temporal Trends in Quality of Life Outcomes After Transapical Transcatheter Aortic Valve Replacement: A Placement of AoRTic TraNscathetER Valve (PARTNER) Trial Substudy.
    Gada H; Kirtane AJ; Wang K; Lei Y; Magnuson E; Reynolds MR; Williams MR; Kodali S; Vahl TP; Arnold SV; Leon MB; Thourani V; Szeto WY; Cohen DJ;
    Circ Cardiovasc Qual Outcomes; 2015 Jul; 8(4):338-46. PubMed ID: 26058718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health Status Benefits of Transcatheter vs Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER 2 Randomized Clinical Trial.
    Baron SJ; Arnold SV; Wang K; Magnuson EA; Chinnakondepali K; Makkar R; Herrmann HC; Kodali S; Thourani VH; Kapadia S; Svensson L; Brown DL; Mack MJ; Smith CR; Leon MB; Cohen DJ;
    JAMA Cardiol; 2017 Aug; 2(8):837-845. PubMed ID: 28658491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transapical aortic valve replacement for severe aortic stenosis: results from the nonrandomized continued access cohort of the PARTNER trial.
    Dewey TM; Bowers B; Thourani VH; Babaliaros V; Smith CR; Leon MB; Svensson LG; Tuzcu EM; Miller DC; Teirstein PS; Tyner J; Brown DL; Fontana GP; Makkar RR; Williams MR; George I; Kirtane AJ; Bavaria JE; Mack MJ
    Ann Thorac Surg; 2013 Dec; 96(6):2083-9. PubMed ID: 23968764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial (Cohort A).
    Reynolds MR; Magnuson EA; Wang K; Thourani VH; Williams M; Zajarias A; Rihal CS; Brown DL; Smith CR; Leon MB; Cohen DJ;
    J Am Coll Cardiol; 2012 Aug; 60(6):548-58. PubMed ID: 22818074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes after transfemoral transcatheter aortic valve replacement: a comparison of the randomized PARTNER (Placement of AoRTic TraNscathetER Valves) trial with the NRCA (Nonrandomized Continued Access) registry.
    Fearon WF; Kodali S; Doshi D; Fischbein MP; Yeung AC; Tuzcu EM; Rihal CS; Babaliaros V; Zajarias A; Herrmann HC; Brown DL; Mack M; Teirstein PS; Whisenant BK; Makkar R; Kapadia S; Leon MB;
    JACC Cardiovasc Interv; 2014 Nov; 7(11):1245-51. PubMed ID: 25459036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and sequelae of prosthesis-patient mismatch in transcatheter versus surgical valve replacement in high-risk patients with severe aortic stenosis: a PARTNER trial cohort--a analysis.
    Pibarot P; Weissman NJ; Stewart WJ; Hahn RT; Lindman BR; McAndrew T; Kodali SK; Mack MJ; Thourani VH; Miller DC; Svensson LG; Herrmann HC; Smith CR; Rodés-Cabau J; Webb J; Lim S; Xu K; Hueter I; Douglas PS; Leon MB
    J Am Coll Cardiol; 2014 Sep; 64(13):1323-34. PubMed ID: 25257633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of patients with chronic lung disease and severe aortic stenosis treated with transcatheter versus surgical aortic valve replacement or standard therapy: insights from the PARTNER trial (placement of AoRTic TraNscathetER Valve).
    Dvir D; Waksman R; Barbash IM; Kodali SK; Svensson LG; Tuzcu EM; Xu K; Minha S; Alu MC; Szeto WY; Thourani VH; Makkar R; Kapadia S; Satler LF; Webb JG; Leon MB; Pichard AD
    J Am Coll Cardiol; 2014 Jan; 63(3):269-79. PubMed ID: 24140659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propensity-matched comparisons of clinical outcomes after transapical or transfemoral transcatheter aortic valve replacement: a placement of aortic transcatheter valves (PARTNER)-I trial substudy.
    Blackstone EH; Suri RM; Rajeswaran J; Babaliaros V; Douglas PS; Fearon WF; Miller DC; Hahn RT; Kapadia S; Kirtane AJ; Kodali SK; Mack M; Szeto WY; Thourani VH; Tuzcu EM; Williams MR; Akin JJ; Leon MB; Svensson LG
    Circulation; 2015 Jun; 131(22):1989-2000. PubMed ID: 25832034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve).
    Généreux P; Cohen DJ; Williams MR; Mack M; Kodali SK; Svensson LG; Kirtane AJ; Xu K; McAndrew TC; Makkar R; Smith CR; Leon MB
    J Am Coll Cardiol; 2014 Mar; 63(11):1100-9. PubMed ID: 24291283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of SAPIEN 3 Transcatheter Valve Implantation on Health Status in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER S3i Trial.
    Baron SJ; Thourani VH; Kodali S; Arnold SV; Wang K; Magnuson EA; Pichard AD; Babaliaros V; George I; Miller DC; Tuzcu EM; Greason K; Herrmann HC; Smith CR; Leon MB; Cohen DJ;
    JACC Cardiovasc Interv; 2018 Jun; 11(12):1188-1198. PubMed ID: 29860075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (cohort A).
    Elmariah S; Palacios IF; McAndrew T; Hueter I; Inglessis I; Baker JN; Kodali S; Leon MB; Svensson L; Pibarot P; Douglas PS; Fearon WF; Kirtane AJ; Maniar HS; Passeri JJ;
    Circ Cardiovasc Interv; 2013 Dec; 6(6):604-14. PubMed ID: 24221391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Health Related Quality of Life in Transcatheter Versus Surgical Aortic Valve Replacement: A Meta-Analysis.
    Ando T; Takagi H; Briasoulis A; Grines CL; Afonso L
    Heart Lung Circ; 2019 Aug; 28(8):1235-1245. PubMed ID: 30172465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial.
    Mack MJ; Leon MB; Smith CR; Miller DC; Moses JW; Tuzcu EM; Webb JG; Douglas PS; Anderson WN; Blackstone EH; Kodali SK; Makkar RR; Fontana GP; Kapadia S; Bavaria J; Hahn RT; Thourani VH; Babaliaros V; Pichard A; Herrmann HC; Brown DL; Williams M; Akin J; Davidson MJ; Svensson LG;
    Lancet; 2015 Jun; 385(9986):2477-84. PubMed ID: 25788234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conventional surgery, sutureless valves, and transapical aortic valve replacement: what is the best option for patients with aortic valve stenosis? A multicenter, propensity-matched analysis.
    D'Onofrio A; Rizzoli G; Messina A; Alfieri O; Lorusso R; Salizzoni S; Glauber M; Di Bartolomeo R; Besola L; Rinaldi M; Troise G; Gerosa G
    J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1065-70; discussion 1070-1. PubMed ID: 24021955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health status after transcatheter aortic valve replacement in patients at extreme surgical risk: results from the CoreValve U.S. trial.
    Osnabrugge RL; Arnold SV; Reynolds MR; Magnuson EA; Wang K; Gaudiani VA; Stoler RC; Burdon TA; Kleiman N; Reardon MJ; Adams DH; Popma JJ; Cohen DJ;
    JACC Cardiovasc Interv; 2015 Feb; 8(2):315-323. PubMed ID: 25700755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health Status After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis.
    Baron SJ; Magnuson EA; Lu M; Wang K; Chinnakondepalli K; Mack M; Thourani VH; Kodali S; Makkar R; Herrmann HC; Kapadia S; Babaliaros V; Williams MR; Kereiakes D; Zajarias A; Alu MC; Webb JG; Smith CR; Leon MB; Cohen DJ;
    J Am Coll Cardiol; 2019 Dec; 74(23):2833-2842. PubMed ID: 31577923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of preoperative moderate/severe mitral regurgitation on 2-year outcome after transcatheter and surgical aortic valve replacement: insight from the Placement of Aortic Transcatheter Valve (PARTNER) Trial Cohort A.
    Barbanti M; Webb JG; Hahn RT; Feldman T; Boone RH; Smith CR; Kodali S; Zajarias A; Thompson CR; Green P; Babaliaros V; Makkar RR; Szeto WY; Douglas PS; McAndrew T; Hueter I; Miller DC; Leon MB;
    Circulation; 2013 Dec; 128(25):2776-84. PubMed ID: 24152861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of Life 5 Years Following Transfemoral TAVR or SAVR in Intermediate Risk Patients.
    Kleiman NS; Van Mieghem NM; Reardon MJ; Gada H; Mumtaz M; Olsen PS; Heiser J; Merhi W; Chetcuti S; Deeb GM; Chawla A; Kiaii B; Teefy P; Chu MWA; Yakubov SJ; Windecker S; Althouse AD; Baron SJ
    JACC Cardiovasc Interv; 2024 Apr; 17(8):979-988. PubMed ID: 38658126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis.
    Reynolds MR; Magnuson EA; Lei Y; Leon MB; Smith CR; Svensson LG; Webb JG; Babaliaros VC; Bowers BS; Fearon WF; Herrmann HC; Kapadia S; Kodali SK; Makkar RR; Pichard AD; Cohen DJ;
    Circulation; 2011 Nov; 124(18):1964-72. PubMed ID: 21969017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal Hemodynamics of Transcatheter and Surgical Aortic Valves in the PARTNER Trial.
    Douglas PS; Leon MB; Mack MJ; Svensson LG; Webb JG; Hahn RT; Pibarot P; Weissman NJ; Miller DC; Kapadia S; Herrmann HC; Kodali SK; Makkar RR; Thourani VH; Lerakis S; Lowry AM; Rajeswaran J; Finn MT; Alu MC; Smith CR; Blackstone EH;
    JAMA Cardiol; 2017 Nov; 2(11):1197-1206. PubMed ID: 28973520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 70.